维普中文期刊产品整合服务
2篇 您的检索式:作者名="Daniel Wiseman"
    题名 作者 年代 出处 被引量
1Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape显示文摘High-quality data remains scarce in terms of optimal management strategies in the elderly inflammatory bowel disease(IBD)population.Indeed,available trials have been mostly retrospective,of small sample size,likely owing to underrepresentation of such a population in the major randomized controlled trials.However,in the last five years,there has been a steady increase in the number of published trials,helping clarify the estimated benefits and toxicity of the existing IBD armamentarium.In the Everhov trial,prescription strategies were recorded over an average follow-up of 4.2 years.A minority of elderly IBD patients(1%-3%)were treated with biologics within the five years following diagnosis,whilst almost a quarter of these patients were receiving corticosteroid therapy at year five of follow-up,despite its multiple toxicities.The low use of biologic agents in real-life settings likely stems from limited data suggesting lower efficacy and higher toxicity.This minireview will aim to highlight current outcome measurements as it portends the elderly IBD patient,as well as summarize the available therapeutic strategies in view of a growing body of evidence.Jean-Frédéric LeBlanc Daniel Wiseman Peter L Lakatos Talat Bessissow 2019World Journal of Gastroenterology2019,25,30:1
2Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism显示文摘Todd W. Swanson Simon K. Chan Steven J. Jones Samuel Bugis Robert Irvine Allan Belzberg Daniel Levine Sam M. Wiseman 2010The American Journal of Surgery2010,,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费